Brain Insulin Resistance in Mood Disorders

Clinical trial NCT03915613 · UNKNOWN

Trial details

NCT number: NCT03915613
Sponsor: University Health Network, Toronto
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Bipolar Disorder Anhedonia Intranasal Insulin

Start date: 2021-10-06
Primary completion: 2024-10-05
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.